Ikarian Capital, LLC 13D and 13G filings for :
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 12:57 pm Purchase |
2022-12-31 | 13G | TRACON Pharmaceuticals, Inc. TCON |
Ikarian Capital, LLC | 138,277 12.500% |
3,721 (+2.77%) |
Filing |
| 2023-02-14 11:26 am Sale |
2022-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR |
Ikarian Capital, LLC | 11,638 0.300% |
-63,845 (-84.58%) |
Filing |
| 2022-02-14 4:43 pm Sale |
2021-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR |
Ikarian Capital, LLC | 75,483 8.100% |
-12,017 (-13.73%) |
Filing |
| 2022-02-14 4:37 pm Sale |
2021-12-31 | 13G | TRACON Pharmaceuticals, Inc. TCON |
Ikarian Capital, LLC | 134,556 13.800% |
-1,287 (-0.95%) |
Filing |
| 2022-02-14 4:35 pm Sale |
2021-12-31 | 13G | scPharmaceuticals Inc. SCPH |
Ikarian Capital, LLC | 901,362 3.300% |
-564,785 (-38.52%) |
Filing |
| 2022-02-14 4:34 pm Unchanged |
2021-12-31 | 13G | Science 37 Holdings, Inc. SNCE |
Ikarian Capital, LLC | 0 0.000% |
0 (Unchanged) |
Filing |
| 2021-04-08 09:02 am Purchase |
2021-03-23 | 13G | X4 Pharmaceuticals, Inc. XFOR |
Ikarian Capital, LLC | 87,500 11.100% |
59,952 (+217.63%) |
Filing |
| 2021-02-16 08:33 am Purchase |
2020-12-31 | 13G | TRACON Pharmaceuticals, Inc. TCON |
Ikarian Capital, LLC | 135,842 17.800% |
27,715 (+25.63%) |
Filing |
| 2021-02-12 4:35 pm Purchase |
2020-12-31 | 13G | scPharmaceuticals Inc. SCPH |
Ikarian Capital, LLC | 1,466,147 5.400% |
392,500 (+36.56%) |
Filing |
| 2021-02-12 4:32 pm Sale |
2020-12-31 | 13G | Strongbridge Biopharma plc SBBP |
Ikarian Capital, LLC | 2,440,028 3.600% |
-802,759 (-24.76%) |
Filing |
| 2021-02-12 4:31 pm Purchase |
2020-12-31 | 13G | KINETA INC KANT |
Ikarian Capital, LLC | 132,514 1.300% |
132,514 (New Position) |
Filing |
| 2021-02-12 4:31 pm Sale |
2020-12-31 | 13G | Verastem, Inc. VSTM |
Ikarian Capital, LLC | 187,883 1.300% |
-233,107 (-55.37%) |
Filing |
| 2020-12-30 5:26 pm Purchase |
2020-12-29 | 13G | X4 Pharmaceuticals, Inc. XFOR |
Ikarian Capital, LLC | 27,547 5.100% |
27,547 (New Position) |
Filing |
| 2020-09-14 5:00 pm Purchase |
2020-09-01 | 13G | TRACON Pharmaceuticals, Inc. TCON |
Ikarian Capital, LLC | 108,127 16.400% |
108,127 (New Position) |
Filing |